Search Results

By Dario Trapani, MD, and Harold J. Burstein, MD, PhD, FASCO  / November 25, 2021

Duration of Endocrine Therapy in Breast Cancer: How Much of a Good Thing Is Too Much?

Estrogen receptor–positive breast cancer is the most common type of breast cancer, diagnosed in more than 2.3 million women around the world each year, including more than 200,000 in the United States alone. Adjuvant endocrine therapy is a mainstay of treatment for these millions of women and is a...